بینش پشت استفاده از بیومارکرهای IFN-G، IL-2، IL-4 و IL-10به‌عنوان نقاط پایانی جانشین برای ابتلا به بیماری-های پوستی ناشی از مواجهه با گاز خردل
Authors
Abstract:
Background and Objective: Here,it is tried to assess an insight behind using IFN-G,IL-2,IL-4,and IL-10 biomarkers as potential surrogate endpoints for skin diseases caused by exposure to mustard gas. Potentially,a biomarker is a valid surrogate if assessment of the treatment effect based on surrogate endpoint leads to the same result based on true clinical endpoint. Materials and Methods: In Sardasht-Iran Cohort study including 328 individuals,235 subjects exposed to mustard gas taken from Sardasht as the exposed group and 93 subjects not exposed to mustard gas taken from Rabat,through comparison of related risk ratios,it is tried to assess whether IFN-G,IL-2,IL-4,and IL-10 biomarkers can be offered as potential surrogates for skin disorders caused by exposure to mustard gas. Results: It was found out that IL-2(at three levels of serum,mitogen and mitogen-nill), IL-10 (at four levels of serum,mitogen,mitogen-nill and nill),and IL-4 (at two levels of mitogen and mitogen-nill) can be used as surrogates,because the survey of no exposure effect of mustard gas based on these biomarkers would led to the same conclusion of the same survey based on existence or non-existence of skin disorders as true clinical endpoint. But IL-4 at serum level and IFN-G at three levels do not have this property. Conclusion: Using IL-2 at three levels, IL-10 at four levels and IL-4 at two levels, the study of no exposure effect of mustard gas on skin disorders can be tested without waiting for skin disorders as the true clinical endpoints.
similar resources
بینش پشت استفاده از بیومارکرهای ifn-g، il-۲، il-۴ و il-۱۰به عنوان نقاط پایانی جانشین برای ابتلا به بیماری-های پوستی ناشی از مواجهه با گاز خردل
مقدمه و هدف: دراین پژوهش هدف آن است که بینش پشت استفاده از بیومارکرهای il-2 ، il-4 ، il-10 و ifn-g به عنوان جانشین های احتمالی ابتلا به بیماری های پوستی ناشی از مواجهه باگازخردل بررسی شود.اگر بتوان بامشاهده یک اثرمعناداردرمان روی جانشین، اثر درمان روی نقطه پایانی بالینی رااستنباط کرد، آنگاه این جانشین میتواندیک جانشین معتبر باشد. مواد و روش ها: در مطالعه همگروهی تاریخی شامل 328نفر، که235نفر...
full textSerum Level of Selenium, IL-4, IL-10 & IFN-g in Patients with Allergic Asthma, Allergic Rhinitis and Healthy Controls
Background: Allergic diseases have increased during the past decade worldwide. Th2 type lymphocyte response is known to play an important role in the process of allergic inflammation. IL-4, a mediator of type II cytokine response increases IgE synthesis and Interferon gamma, a cytokine of type I response interferes with IL-4 and inhibits IgE production. Selenium is an essential component of glu...
full textIFN-g-Inducing Factor/IL-18 Administration Mediates IFN-g- and IL-12-Independent Antitumor Effects
full text
Synergistic Effects of IL-4 and IL-18 on IL-12-Dependent IFN-g Production by Dendritic Cells
full text
Evaluation of Relation between IL-4 and IFN-y Polymorphisms and Type 2 Diabetes
Objective(s) Although, type 2 diabetes is the most frequent type of diabetes, its main cause is yet to be clarified. Several environmental and genetic parameters are believed to be involved in diabetes. It has also been established that cytokines play key roles in pathogenesis of diabetes. Expression of cytokines is different from person to person and in different societies. Several studies sh...
full textIL-4 synergistically enhances both IL-2– and IL-12–induced IFN- expression in murine NK cells
http://bloodjournal.hematologylibrary.org/content/102/1/207.full.html Updated information and services can be found at: (1930 articles) Signal Transduction (4939 articles) Immunobiology (1086 articles) Gene Expression Articles on similar topics can be found in the following Blood collections http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#repub_requests Information abo...
full textMy Resources
Journal title
volume 17 issue 88
pages 1- 8
publication date 2010-09
By following a journal you will be notified via email when a new issue of this journal is published.
No Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023